The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lin Patrick since 2020.
This trader's CIK number is 1799363.
At the time of last reporting, Lin Patrick was the Chief Business - Strategy Off of Processa Pharmaceuticals, Inc.. (stock ticker symbol PCSA).
Also see all insider trading activities at Processa Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | PCSA | 43,500 | $34,713 | 0 | $0 | 14,482 | $0 |
| 2024 | PCSA | 4,000 | $9,525 | 0 | $0 | 3,994 | $0 |
| 2022 | PCSA | 7,000 | $21,777 | 0 | $0 | 0 | $0 |
| 2021 | PCSA | 12,500 | $66,184 | 0 | $0 | 0 | $0 |
| 2020 | PCSA | 31,250 | $65,625 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-04-01 | PCSA | Option Ex | 14,482 | .00 | 0 |
| 2025-01-27 | PCSA | Buy | 43,500 | .80 | 34,713 |
| 2024-07-10 | PCSA | Option Ex | 644 | .00 | 0 |
| 2024-04-05 | PCSA | Option Ex | 1,675 | .00 | 0 |
| 2024-01-01 | PCSA | Option Ex | 1,675 | .00 | 0 |
| 2024-02-01 | PCSA | Buy | 1,500 | 2.40 | 3,600 |
| 2024-01-31 | PCSA | Buy | 2,500 | 2.37 | 5,925 |
| 2022-05-17 | PCSA | Buy | 2,000 | 1.59 | 3,190 |
| 2022-04-06 | PCSA | Buy | 1,200 | 3.13 | 3,752 |
| 2022-04-07 | PCSA | Buy | 800 | 3.54 | 2,835 |
| 2021-12-14 | PCSA | Buy | 3,000 | 4.00 | 12,000 |
| 2021-12-14 | PCSA | Buy | 3,000 | 4.00 | 12,000 |
| 2021-12-03 | PCSA | Buy | 3,500 | 4.80 | 16,796 |
| 2021-08-26 | PCSA | Buy | 4,000 | 6.02 | 24,088 |
| 2021-06-21 | PCSA | Buy | 2,000 | 6.65 | 13,300 |
| 2020-10-01 | PCSA | Buy | 31,250 | 2.10 | 65,625 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lin Patrick (Chief Business - Strategy Off of Processa Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.